CHOC

CHOC was established to function as a group purchasing organization for POHMS members and to share any benefits derived from group purchasing activities.

CHOC selects a preferred vendor, based on a competitive bid process, to provide aggressive drug pricing, payment terms and a variety of related services to eligible CHOC member practices.

Solid Reputation

CHOC believes every practice has full control over their ability to buy whatever drugs they choose. CHOC’s goal is to assist members with making well-informed decisions.

Eisai

In the first quarter of 2008, Eisai, Inc. purchased MGI Pharma. Eisai Inc. (pronounced â-zî) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Established in 1995, Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with sales of approximately $2.6 billion in fiscal year 2006 (year ending March 31, 2007).

Headquartered in Woodcliff Lake, New Jersey, we are dedicated to a tradition of genuine concern for people and are driven by the desire to meet the diverse health care needs of patients and their families and caregivers. We are an agile, entrepreneurial organization managed by experienced leadership, backed by the strength, stability and historical successes of Eisai Co., Ltd.., which has a strong and lasting commitment to the U.S. market.

Genentech

Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for almost 30 years, using human genetic information to discover, develop, commercialize and manufacture biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions and over 40 projects in the pipeline. The company is the leading provider of anti-tumor therapeutics in theUnited States. With its strength in all areas of the drug development process — from research and development to manufacturing and commercialization — Genentech continues to transform innovative science into breakthrough therapies for patients. For more general information about the company, visit our corporate overview section.

Oncology Supply

Oncology Supply is the nation’s largest distributor of Chemotherapy drugs & Supplies, earning a respected name in the wholesale specialty arena with more than 30 years of experience.  For the community-based oncology practice, Oncology Supply has become the first choice for reliability, stability, integrity and honesty.   Bringing technology to the forefront, Oncology Supply’s Nucleus® cabinet offers support and solutions for your practice’s inventory management needs.  Our goal is to deliver responsive and innovative solutions to help our business partners positively impact cancer patients’ lives. For more information, visit www.oncologysupply.com.

Lilly

Lilly is a pioneer in chemotherapy drugs, having introduced vincristine and vinblastine in the 1960s. These anticancer drugs, known as vinca alkaloids, were derived from the rosy periwinkle plant. In 1996, Lilly leveraged this expertise with the introduction of GEMZAR® (gemcitabine HCl for injection) for the treatment of non-small cell lung cancer, pancreatic cancer, and metastatic breast cancer.

Janssen Biotech

Ortho Biotech Products, L.P. is a leading biopharmaceutical company that provides innovative products and services designed to help enhance the lives of individuals with serious chronic illnesses. We market a prescription medication for chemotherapy-related anemia in patients with most types of cancer, for kidney disease patients with anemia who are not on dialysis, for anemia induced by AZT-containing regimens in HIV patients, and for patients undergoing elective, non-cardiac, non-vascular surgery who are anemic. More than two million patients in the United States alone have been treated with our products.

US Oncology

Oncology Pharmaceutical Services offers community-based oncology practices a range of services designed to increase practice success – especially in today’s turbulent reimbursement environment.
The oncology drug management process is complex, and minor inefficiencies can significantly impact both quality and practice performance. Our programs and services help the community-based oncology practice optimize their drug management processes. These time-tested programs and services reflect oncology pharmacy best practices and are tailored to fit the needs of each specific practice.

McKesson Specialty Health

Allos Therapeutics, Inc.

Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics.

Amgen

Amgen is a leading human therapeutics company in the biotechnology industry. For 25 years, the company has tapped the power of scientific discovery and innovation to dramatically improve people’s lives.

Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.

Baxter

Millenium

Millennium has a major commitment to the discovery and development of new treatments for cancer, with a sizeable group focused on this area, including cancer biologists, world-leading experts in the field of genomics-based oncology and clinical oncology researchers. Our overall strategy in oncology is to develop novel treatments based on a thorough understanding of the molecular pathways that underlie different forms of cancer, and of the most appropriate points for therapeutic intervention within these pathways.

Merck

Novartis

Sanofi Aventis

McKesson

OncoMed

Pfizer

AMAG Pharmaceutical

Innovatix

ACRO Pharmaceutical

Caris Life Sciences